2026 quality measures for MIPS reporting
2026 QCDR measure specifications
Access a spreadsheet of 2026 QCDR measure specifications.
Access 2026 MIPS quality measures by selecting below.
Advance Care Plan
Documentation of Current Medications in the Medical Record
Tuberculosis Screening Prior to First Course Biologic and/or Immune Response Modifier Therapy
Tobacco Use: Screening and Cessation Intervention
Controlling High Blood Pressure
Use of High-Risk Medications in Older Adults 2026
Patient-Centered Surgical Risk Assessment and Communication
Closing the Referral Loop: Receipt of Specialist Report
Melanoma Reporting
Psoriasis: Clinical Response to Systemic Medications
Unhealthy Alcohol Use: Screening & Brief Counseling
Skin Cancer: Biopsy Reporting Time – Pathologist to Clinician
Psoriasis – Improvement in Patient-Reported Itch Severity
Dermatitis – Improvement in Patient-Reported Itch Severity
Adult Immunization Status
Gains in Patient Activation Measure (PAM) Scores at 12 Months
Melanoma: Tracking and Evaluation of Recurrence
Access 2026 QCDR measures by selecting below.
Skin Cancer: Biopsy Reporting Time – Clinician to Patient
Chronic Skin Conditions: Patient Reported Quality-of-Life
Melanoma: Appropriate Surgical Margins
Psoriasis – Appropriate Assessment & Treatment of Severe Psoriasis
Avoidance of Post-operative Systemic Antibiotics for Office-based Closures and Reconstruction After Skin Cancer Resection Procedures
Actinic Keratosis: Patient-reported Treatment Effectiveness and Care Satisfaction
Actinic Keratosis: Appropriate Documentation and Shared Decision Making of AK
Find a Dermatologist
Member directory
AAD Learning Center
2026 AAD Annual Meeting
Need coding help?
Reduce burdens
Clinical guidelines
Why use AAD measures?
New insights
Physician wellness
Joining or selling a practice?
Promote the specialty
Advocacy priorities